‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial shows
- Posted on October 23, 2026
- By The Guardian
- 0 Views
- 1 min read
In brief
Generating AI summary…
‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial shows
Trial results represent ‘foundational shift’ in approach to cancer, allowing scientists to harness immune system in more personalised way
